Toggle light / dark theme

Melanized fungi although dangerous to human biology actually are remarkable because they adapted to the radiation which could give more clues to how humans could evolve to survive radiation exposure long term.


There’s an organism thriving within the Chernobyl disaster zone that is not only enduring some of the harshest living conditions imaginable, but potentially helping to improve them too.

The fallout from the Chernobyl nuclear disaster in 1986 is still fascinating the scientific community nearly 40 years on, with new developments emerging all the time.

The Chernobyl Exclusion Zone in Ukraine features a level of radiation that is six times the legal limit of human exposure for workers at 11.28 millirem – but there is still a living organism that has adapted to live and thrive there.

Is an in-depth investigation featuring world renowned philosophers and scientists into the most profound philosophical debate of all time: Do we have free will?

Featuring: Sean Carroll, Daniel Dennett, Jerry Coyne, Dan Barker, Heather Berlin, Gregg Caruso, Massimo Pigliucci, Alex O’Conner, Coleman Hughes, Edwin Locke, Robert Kane, Rick Messing, Derk Pereboom, Richard Carrier, Trick Slattery, Dustin Kreuger, Steven Sharper, Donia Abouelatta.

Chapters.

Intro: — 0:00
Chapter 1: What is Free Will? — 4:19
Chapter 2: The Problem of Free Will — 15:29
Interlude: 22:33
Chapter 3: Libertarian Free Will — 23:16
Chapter 4: Compatibilism — 34:47
Chapter 5: Free Will Skepticism — 45:13
Interlude: The 3 Positions of Free Will — 55:45
Chapter 6: The Great Debate — 57:28
Chapter 7: Neuroscience — 1:07:28
Chapter 7: The Interaction Problem — 1:18:37
Chapter 8: Physics — 1:20:10
Chapter 8: Reduction & Emergence — 1:22:14
Chapter 9: Can We Have Determinism and Free Will? — 1:28:57
Chapter 10: Free Will and the Law — 1:45:57
Chapter 11: Should We Stop Using the Term Free Will? — 1:56:37
Outro: 2:00:38

In today’s AI news, Investor interest in AI coding assistants is exploding. Anysphere, the developer of AI-powered coding assistant Cursor, is in talks with venture capitalists to raise capital at a valuation of nearly $10 billion, Bloomberg reported. The round, if it transpires, would come about three months after Anysphere completed its previous fundraise of $100 million at a pre-money valuation of $2.5 billion.

And, there’s a new voice model in town, and it’s called Sesame. As he so often does, John Werner got a lot of information on this new technology from Nathaniel Whittemore at AI Daily Brief, where he covered interest in this conversational AI. Quoting Deedy Das of Menlo Ventures calling Sesame “the GPT-3 moment for voice,” Whittemore talked about what he called an “incredible explosion” of voice-based models happening now.

In other advancements, along with the new M4 MacBook Pro series Apple is releasing, the company is also quite proud of the new Mac mini. The Mac mini is arguably the more radical of the two. Apple’s diminutive computer has now received its first major design overhaul in 13 years. And this new tiny computer is the perfect machine for experimenting with and learning AI.

S biggest defense tech startups by valuation, raising $240 million at a $5.3 billion valuation in its latest round. Shield AI, the San Diego defense tech startup that builds drones and other AI-powered military systems, has raised a $240 million round at a $5.3 billion valuation, it announced today.” + In videos, while he hardly needs an introduction, few leaders have shaped the future of technology quite like Satya Nadella. He stepped into Microsoft’s top job at a catalytic moment—making bold bets on the cloud, embedding AI into the fabric of computing, all while staying true to Microsoft’s vision of becoming a “software factory.”

T just think, it delivers results. Manus excels at various tasks in work and life, getting everything done while you rest. + Then, join Boris Starkov and Anton Pidkuiko, the developers behind GibberLink, for a fireside chat with Luke Harries from ElevenLabs. On February 24, Georgi Gerganov, the creator of the GGwave protocol, showcased their demo at the ElevenLabs London hackathon on X, garnering attention from around the world—including Forbes, TechCrunch, and the entire developer community.

We close out with, Sam Witteveen looking at the latest release from Mistral AI, which is their Mistral OCR model. He looks at how it works and how it compares to other models, as well as how you can get started using it with code.

Thats all for today, but AI is moving fast — subscribe and follow for more Neural News.

“The Future Already Happened“
What if the past isn’t fixed? Scientists have just proven that the future can influence the past, shattering everything we thought we knew about time and reality. From mind-bending quantum experiments to the shocking science of precognition, this video explores the hidden connections between time, consciousness, and the universe.

✅GET YOUR FREE NUMEROLOGY READING HERE:
https://bit.ly/full-numerology-reading.

Time Stamps:

0:00 — Mind-Blowing Experiments.
1:43 — Presentiment.
2:26 — Precognition.
5:12 — J.W. Dunne’s Precognitive Dream Protocol.
7:33 — Feeling The Future.
10:00 — Remote Viewing.
12:18 — Free Will & Retrocausality.
14:43 — Lucid Dreaming.

►Copyright ©:
Script — BE INSPIRED
Narration — BE INSPIRED
Footage is licensed through Videoblocks, Artgrid, and Envato.
Music: Epidemic Sound / Audiojungle / Envato Elements.
Interviews / Video References were used under FAIR USE LAW.

© BE INSPIRED CHANNEL — All rights reserved.

On the weekend Elon Musk provided a live demonstration of Neuralink’s technology using pigs with surgically implanted brain monitoring devices. The Australian Society for Computers & Law invited Dr Michelle Sharpe (Victorian Barrister) and Dr Allan McCay (Lecturer and Author on Neurotechnology and the law) to explore the legal and ethical implications of technology that interfaces between the human brain and computer devices.

Abstract: Hallucination is a persistent challenge in large language models (LLMs), where even with rigorous quality control, models often generate distorted facts. This paradox, in which error generation continues despite high-quality training data, calls for a deeper understanding of the underlying LLM mechanisms. To address it, we propose a novel concept: knowledge overshadowing, where model’s dominant knowledge can obscure less prominent knowledge during text generation, causing the model to fabricate inaccurate details. Building on this idea, we introduce a novel framework to quantify factual hallucinations by modeling knowledge overshadowing. Central to our approach is the log-linear law, which predicts that the rate of factual hallucination increases linearly with the logarithmic scale of Knowledge Popularity, Knowledge Length, and Model Size. The law provides a means to preemptively quantify hallucinations, offering foresight into their occurrence even before model training or inference. Built on overshadowing effect, we propose a new decoding strategy CoDa, to mitigate hallucinations, which notably enhance model factuality on Overshadow (27.9%), MemoTrap (13.1%) and NQ-Swap (18.3%). Our findings not only deepen understandings of the underlying mechanisms behind hallucinations but also provide actionable insights for developing more predictable and controllable language models.

From: Yuji Zhang [view email].

Have you ever questioned the deep nature of time? While some physicists argue that time is just an illusion, dismissing it outright contradicts our lived experience. In my latest work, Temporal Mechanics: D-Theory as a Critical Upgrade to Our Understanding of the Nature of Time (2025), I explore how time is deeply rooted in the computational nature of reality and information processing by conscious systems. This paper tackles why the “now” is all we have.

In the absence of observers, the cosmic arrow of time doesn’t exist. This statement is not merely philosophical; it is a profound implication of the problem of time in physics. In standard quantum mechanics, time is an external parameter, a backdrop against which events unfold. However, in quantum gravity and the Wheeler-DeWitt equation, the problem of time emerges because there is no preferred universal time variable—only a timeless wavefunction of the universe. The flow of time, as we experience it, arises not from any fundamental law but from the interaction between observers and the informational structure of reality.

Mushrooms are probably the most miraculous entities because each mushroom can aid in a different way to cure each illness in the human biology. Much like cannabis is actually a cure all for so many ailments in humans so in turn are mushrooms able to do the same.


Alzheimer’s disease (AD) stands as a formidable neurodegenerative ailment and a prominent contributor to dementia. The scarcity of available therapies for AD accentuates the exigency for innovative treatment modalities. Psilocybin, a psychoactive alkaloid intrinsic to hallucinogenic mushrooms, has garnered attention within the neuropsychiatric realm due to its established safety and efficacy in treating depression. Nonetheless, its potential as a therapeutic avenue for AD remains largely uncharted. This comprehensive review endeavors to encapsulate the pharmacological effects of psilocybin while elucidating the existing evidence concerning its potential mechanisms contributing to a positive impact on AD. Specifically, the active metabolite of psilocybin, psilocin, elicits its effects through the modulation of the 5-hydroxytryptamine 2A receptor (5-HT2A receptor). This modulation causes heightened neural plasticity, diminished inflammation, and improvements in cognitive functions such as creativity, cognitive flexibility, and emotional facial recognition. Noteworthy is psilocybin’s promising role in mitigating anxiety and depression symptoms in AD patients. Acknowledging the attendant adverse reactions, we proffer strategies aimed at tempering or mitigating its hallucinogenic effects. Moreover, we broach the ethical and legal dimensions inherent in psilocybin’s exploration for AD treatment. By traversing these avenues, We propose therapeutic potential of psilocybin in the nuanced management of Alzheimer’s disease.

Alzheimer’s disease (AD) is a progressive neurodegenerative disease that is the leading cause of dementia in the elderly population (Anonymous, 2021). It is characterized by the deposition of amyloid-beta (Aβ) plaques, tau neurofibrillary tangles, and neuroinflammation (Scheltens et al., 2021). The prevalence of dementia is expected to rise as the global population grows and ages, with projections estimating a significant increase in the number of cases (Anonymous, 2022b). In 2019, the total cost of healthcare, long-term care, and hospice services for individuals aged 65 years and older with dementia in the United States was estimated at $2.2billion, so AD imposes a substantial burden on individuals, families, society, and the economy (Anonymous, 2022a). The U.S. Food and Drug Administration (FDA) has approved seven drugs for the treatment of AD, including rivastigmine, donepezil, galantamine, memantine, memantine combined with donepezil, aducanumab and lecanemab.

If you think telepathy or mind control is the stuff of science fiction, think again. Advances in artificial intelligence are leading to medical breakthroughs once thought impossible, including devices that can actually read minds and alter our brains.

Can we mobilise society towards a concerted effort against ageing? Dr Aubrey de Grey believes so—with groundbreaking results from studies by the Longevity Escape Velocity (LEV) Foundation on Integrative Rejuvenation, a cutting-edge approach to repairing cellular and molecular damage linked to ageing.

Why does he believe this could be the most promising pathway toward extending healthy human lifespan? Watch on to find out.

Register for upcoming #HealthyLongevity #webinar sessions at https://nus-sg.zoom.us/webinar/regist… The opinions and advice expressed in this webinar are those of the speakers and do not represent the views and opinions of the organizers and National University of Singapore or any of its subsidiaries or affiliates. The information provided in this webinar is for general information purposes only as part of a general discussion on public health. The information is not intended to be a substitute for professional medical advice, diagnoses or treatment; and cannot be relied on in place of consultation with your licensed healthcare provider. All Rights Reserved. All of the proceedings of this webinar, including the presentation of scientific papers, are intended for limited publication only, and all property rights in the material presented, including common-law copyright, are expressly reserved to the speaker or NUS. No statement or presentation made is to be regarded as dedicated to the public domain. Any sound reproduction, transcript or other use of the material presented at this course without the permission of the speaker or NUS is prohibited to the full extent of common-law copyright in such material.

Disclaimer: The opinions and advice expressed in this webinar are those of the speakers and do not represent the views and opinions of the organizers and National University of Singapore or any of its subsidiaries or affiliates. The information provided in this webinar is for general information purposes only as part of a general discussion on public health. The information is not intended to be a substitute for professional medical advice, diagnoses or treatment; and cannot be relied on in place of consultation with your licensed healthcare provider. All Rights Reserved.

All of the proceedings of this webinar, including the presentation of scientific papers, are intended for limited publication only, and all property rights in the material presented, including common-law copyright, are expressly reserved to the speaker or NUS. No statement or presentation made is to be regarded as dedicated to the public domain.

Any sound reproduction, transcript or other use of the material presented at this course without the permission of the speaker or NUS is prohibited to the full extent of common-law copyright in such material.